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ABSTRACT
Objective: To assess the direct cost of dressings in pressure ulcer treatment. Method:  This 
was a descriptive observational study conducted at an intensive care unit in the Northeast 
region of Brazil, between November and December 2015. Data were gathered using the 
Pressure Ulcer Scale for Healing and a form to characterize and assess costs. Values in 
Brazilian reais (BRL) were converted into U.S. dollars at the exchange rate of USD 0.26/
BRL. Univariate and bivariate analyses were conducted. Results: The sample consisted 
of 15 patients with at least stage 2 ulcers. There was a significant reduction in costs with 
dressing materials between the initial and final assessments (p=0.002), with a mean of 
USD 11.9 (±7.4). The most common topical treatments used were essential fatty acids and 
papain. Conclusion: Cost reduction was proportional to the stage of pressure ulcer. The 
role of nurses in creating evidence-based care plans is crucial to improve care management.
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INTRODUCTION
Pressure Ulcers (PUs) significantly impact patients, fam-
ily members and health systems, in that they are recurring, 
debilitating and negatively impact quality of life by caus-
ing pain, suffering, increased length of hospital stay or even 
death. Furthermore, they require lasting treatment and are 
associated with high rates of morbidity, mortality, and costs(1), 
especially those related to dressings.
Pressure ulcers are localized injuries to the skin and/or 
underlying tissues, usually over a bony prominence or in asso-
ciation with care devices, resulting from sustained pressure, or 
a combination of pressure and shear. Classification indicates 
the level of tissue injury: stage 1, nonblanchable erythema on 
intact skin; stage 2, partial loss of skin thickness with exposed 
dermis; stage 3, total loss of skin thickness; stage 4, total loss 
of skin thickness and tissue loss; nonstageable, when there is 
nonvisible tissue loss; and deep tissue pressure ulcer, persistent 
and nonblanchable maroon, brown, or purple discoloration(2).
Treatment for pressure ulcers incurs in high costs for 
health services, especially stage 3 and 4, as they require a great 
amount of material and human resources. Audits conducted 
in public health services have shown that inconsistent wound 
care management practices and the use of outdated methods 
contribute to such high costs and ineffective outcomes(3).
Health costs in Brazil are high and have been rising 
quickly, making it difficult to maintain the sustainability of 
health systems, which is intensified by the current global eco-
nomic crisis. Managers, providers, funding agencies, authori-
ties and users have been progressively concerned with costs 
and how they influence quality of service(4).
Within the context of research, there is a shortage of 
quality evidence that indicate the profitability of interven-
tions and poor methodological definition and structuring of 
economic assessment, with explanations about the unit of 
cost of the analysis, inclusions, and cost calculation. Thus, 
treatment is measured through a combination of clinical, 
economic and/or humanistic outcomes(5).
The efficacy, effectiveness and efficiency of health services 
are aimed at optimizing care practices without losing sight 
of the cost perspective(6). Economic assessment studies are 
important administrative and resource distribution tools to 
reduce costs for health systems and clients alike(7).
In light of the above, the aim of the present study was 
to assess the direct costs of dressing materials used in PU 
treatment in an intensive care unit part of a university hos-
pital in order to produce scientific knowledge on the topic, 
considering its relevance and impact on health management.
METHOD
This was an observational and analytical study conducted 
at a 10-bed intensive care unit (ICU) at a university hospital 
in the Northeast region of Brazil, between November and 
December 2015. Nonprobabilistic sampling was used and the 
inclusion criteria were: patients 18 years or older undergoing 
treatment for PU. Seven cases that did not require wound 
dressings or the ones that could not be observed completely, 
including one death and one transfer to another unit, were 
excluded. Thus, the sample consisted of 15 patients.
Data were collected using a three-part form: The first 
included sociodemographic (age, gender, marital status and 
education level) and general clinical data (clinical diagnosis, 
mobility, comorbidities, nutritional risk). Nutritional risk was 
assessed with the Nutritional Risk Screening tool, which 
is composed of two dimensions: nutritional condition and 
disease severity, measured on an ordinal scale from 0 to 3. 
The final result was represented by the sum of the scores, and 
patients with values equal or higher than 3 were considered 
to be at nutritional risk(8). The second section gathered data 
on wound characteristics, and the third presented a checklist 
with the materials used during procedures.
The researchers adopted the third edition of the 
Portuguese version of the Pressure Ulcer Scale for Healing 
(PUSH), validated in 2005, to monitor wound healing and 
thus assess the treatment given to patients. The scale evalu-
ates three parameters: wound surface area (0 to 10 points, 
from 0 to greater than 24 cm²), exudate quantity (0 to 3: 
none to heavy) and tissue type (0 to 4: intact to necrotic). 
The total possible score ranges from 0 to 17 points. The 
assessment was longitudinal, in that higher scores indicated 
worsened conditions and lower scores indicated improved 
wound conditions(9).
There is no minimum or maximum indication for apply-
ing the PUSH. The researchers established five observations 
per patient with a four-day interval between observations, 
so that differences could be perceived between assessments, 
considering the wound healing process(9). During the time 
span covered in this study, each patient presented only one 
pressure ulcer.
First, patients undergoing PU treatment were identified 
through information on patient charts. Dressing changes 
were observed and the researchers recorded the materials 
used and measured the wounds with disposable rulers. The 
scale was applied to measure and classify wounds as per inter-
national panel guidelines(10).
Each patient was assessed five times, totaling 75 obser-
vations. The observed dressing changes were carried out by 
nurses during patients’ bed baths and all the beds used pneu-
matic mattresses.
Later, information was gathered from the hospital 
administration and financial sector about the unit cost of 
the materials used. Hospital materials were acquired through 
procurement processes, and the values considered for calcula-
tion in this study corresponded to the procurement in force 
at the time of the study. Original values in Brazilian Reais 
(BRL) were converted into U.S. dollars (USD) based on the 
exchange rate of BRL 1 to USD 0.26 (December 15, 2015).
The data were analyzed using the Statistical Package 
for the Social Sciences®, version 18.0, generating descriptive 
statistics, such as mean, standard deviation, minimum and 
maximum values for quantitative variables and frequency for 
categorical values. For inferential analyses, the Shapiro-Wilk 
test was conducted to verify the normality of distribution 
and the Wilcoxon Signed-Rank test and Student’s t-test 
were used to compare costs in relation to wound assess-
ment, with a confidence interval of 95% and significance 
level set at 5%.
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All stages of this study were abided by the ethical prin-
ciples set forth in Resolution no. 466/2012 of the Brazilian 
National Health Council and by international standards for 
research with humans. The study was approved by a research 
ethics committee under ruling no. 1.197.638/2015.
RESULTS
Fifteen (100%) patients participated in this study. 
Mean age was 52.2 (±20.7) years, ranging from 19 to 81 
years. Most of the sample was composed of women (8, 
53.3%), and 6 (40%) were single, 3 (20%) were married, 4 
(26.7%) were divorced, and 2 (13.3%) were widowers. Most 
of the participants had not completed elementary school 
(9 (60%). The most common reasons for ICU admission 
were respiratory problems (7, 46.6%), circulatory prob-
lems (4, 26.7%) and digestive problems (4, 26.6%). In 
addition to the baseline diagnosis, they presented the fol-
lowing comorbidities: systemic arterial hypertension (8, 
53.3%), diabetes mellitus (3, 20.0%), chronic kidney failure 
(3, 20.0%), systemic lupus erythematosus (3, 20.0%), and 
neurological disorders (2, 13.3%). Four patients (26.6%) 
were at nutritional risk.
All the patients were bedridden with PUs located in 
the sacral region (15, 100%): 6 (40.0%) presented stage 2 
ulcers, 6 (40.0%) had stage 3 ulcers, 1 (6.7%), stage 4, and 
2 (13.3%) were unstageable, with nonvisible tissue loss. At 
the first assessment, average wound surface area was 47.6 
(±31.4) cm2, with a minimum of 12 and a maximum of 
126 cm2, while at the final assessment, surface areas ranged 
from 6 cm2 to 108 cm2, with a mean of 40.9 (±29.7), show-
ing a statistically significant difference (p=0.007). PUSH 
scores also presented significant differences between the 
mean of the first assessment (13.5, ±1.2) and last assessment 
(12.5, ±1.9), whose minimum value dropped from 11 to 8, 
and maximum value, from 16 to 15 (p=0.034).
Wound healing was assessed based on the comparison 
of the first and last PUSH score. Six (40%) of the PUs pre-
sented positive healing processes, with a 3.5-point reduc-
tion in mean score (initial: 14; final: 11.5). Only 1 (6.7%) 
presented negative evolution, with a one-point increase in 
mean scores (initial: 14; final: 15), and most of the wounds 
(8, 53.3%) maintained the same PUSH score, with a mean 
of 13. The amount of materials used in the observed dressing 
procedures (n=75) and the total direct cost of each item are 
presented in Table 1.
Table 1 – Total cost of materials used in dressing procedures – Teresina, Piauí, Brazil, 2016.
Materials Unit
Quantity Total cost (USD)
n (%)* Min-Max M (±SD) Min-Max M (±SD)
Needle - 59 (100) 0.0-13.0 4.0 (2.8) 0.0-1.1 0.3 (0.2)
0.9% saline solution 100 ml 48 (100) 0.0-5.0 3.2 (1.2) 0.0-1.9 1.2 (0.4)
0.9% saline solution ampoule 10 ml 70 (100) 0.0-15.0 4.7 (3.6) 0.0-1.9 1.2 (0.5)
Scalpel and safety handle - 21 (100) 1.0-2.0 1.4 (0.5) 0.8-1.6 1.1 (0.4)
Procedure gloves Pair 77 (100) 5.0-6.0 5.1 (0.4) 0.5-0.5 0.4 (0.0)
Surgical gloves Pair 75 (100) 5.0-5.0 5.0 (-) 1.2-1.2 1.2 (-)
Sterile gauze 20-unit pack 121 (100) 5.0-12 8.0 (2.8) 1.0-2.3 1.6 (0.5)
Micropore tape cm 5265 (100) 175.0-460.0 351.0 (76.6) 0.2-0.3 0.3 (0.5)
EFA ml 280 (100) 0.0-81.00 18.7 (20.7) 0.0-0.6 0.2 (0.2)
Papain 8% g 83 (100) 0.0-26.0 5.5 (8.6) 0.0-2.3 0.5 (0.8)
Papain 10% g 165 (100) 0.0-31.0 11.0 (10.6) 0.0-2.5 0.9 (0.8)
Silver Sulfadiazine g 43 (100) 0.0-30.0 2.9 (8.2) 0.0-0.5 0.1 (0.1)
Sterile gauze compresses 5-unit pack 22 (100) 0.0-7.0 1.5 (2.4) 0.0-19.1 4.0 (6.5)
Total - 75 (100)** - - 5.2-27.7 11.9 (7.4)
Legend: M (±SD): mean and standard deviation; Min-Max: minimum and maximum costs; *Used on all of the observed patients; **total dressing procedures performed. 
Note: (n=75).
Cost calculation considered the amount of materials used 
in each dressing procedure per observation and their unit 
value. The highest costs were associated with sterile com-
presses (USD 4.0, ±6.5) and the values of topical treatments 
varied between USD 0.1 to 0.9. Maximum total cost was 
USD 27.7, with a mean of 11.9 (±7.4), as shown in Table 1. 
Table 2 presents costs by PU stage.
The total cost of dressing materials, considering the five 
observations conducted per patient, was higher among stage 
4 ulcers, with a mean of USD 27.7, followed by stage 3 
ulcers, with USD 14.1. The minimum value of stage 2 ulcers 
was USD 1.3 higher than stage 3 ulcers, and the maximum 
was USD 11.1 lower.
The difference between the mean costs of stage 2 and 
3 ulcers was USD 5.9 and no statistically significant dif-
ferences were observed in the total overall cost among PU 
categories (p=0.252) (Table 2). Table 3 presents a compari-
son between the total cost of PU care (15, 100%) at the first 
and last assessments.
Wounds with slough tissue presented a one-unit increase 
(1, 6.7%), however dressing-related expenses decreased USD 
1.4 (p=0.028). Those with necrotic tissue presented a 5-unit 
reduction (33.3%) and the mean total cost of dressings dropped 
USD 1.7 between the initial and final assessments (p=0.036). 
The costs of materials used on wounds with absent exudate 
decreased USD 1.7 (p=0.018), and in quantity 6 (40%).
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Table 2 – Total cost of dressing materials by stage of pressure ulcer – Teresina, Piauí, Brazil, 2016.
Stage of pressure ulcer n(%)
Total cost (USD)
Min-Max M(±SD)
Stage 2 6 (40.0) 6.5-13.1 8.2 (2.4)
Stage 3 6 (40.0) 5.2-24.2 14.1 (8.4)
Stage 4 1 (6.7) 27.7-27.7 27.7 (-)
Unstageable 2 (13.3) 7.8-9.0 8.4 (0.9)
Total 15 (100) 5.2-27.7 11.9 (7.4)
Legend: M (±SD): mean and standard deviation; Min-Max: minimum and maximum costs. Note: (n=15).








Min-Max M (±SD) Min-Max M (±SD)
Tissue type
Epithelial - - - 1 (6.7) 0.7-0.7 0.7 (-) -*
Granulation 1 (6.7) 2.7-2.7 2.7 (-) 4 (26.6) 1.1-4.0 1.9 (1.4) 0.068u
Slough 6 (40.0) 1.1-5.5 3.4 (2.0) 7 (46.7) 0.7-4.5 2.0 (1.7) 0.028u
Necrotic 8 (53.3) 1.1-4.4 2.4 (1.3) 3 (20.0) 0.8-1.1 0.7 (0.2) 0.036u
Exudate amount
None 7 (46.7) 1.4-5.5 2.4 (1.5) 1 (6.7) 0.7-0.7 0.7 (-) 0.018u
Light 5 (33.3) 1.1-5.1 2.4 (1.6) 12 (80.0) 0.7-4.5 1.6 (1.4) 0.080u
Moderate 3 (20.0) 4.3-5.0 4.6 (0.4) 2 (13.3) 1.4-4.0 2.7 (1.9) 0.280u
Wound surface area 15 (100) 1.1-5.5 3.3 (1.6) 15 (100) 0.7-4.5 2.4 (1.7) 0.002t
4.1-8.0 cm² - - - 2 (13.3) 0.7-1.1 0.9 (0.3) -*
8.1-12.0 cm² 2 (13.3) 1.5-5.0 3.2 (2.5) 2 (13.3) 0.7-1.1 0.9 (0.3) 0.180u
12.1-24 cm² 2 (13.3) 1.4-2.3 1.8 (0.6) - - - -*
>24 cm² 11 (73.4) 1.1-5.5 2.9 (1.6) 11 (73.4) 0.8-4.5 1.9 (1.6) 0.008u
PUSH 15 (100) 1.1-5.5 2.9 (1.5) 15 (100) 0.7-4.5 1.7 (1.4) 0.001t
Exudate aspect
Absent 7 (46.7) 1.4-5.5 2.4 (1.5) 1 (6.7) 0.7-0.7 0.7 (-) 0.020u
Serous 1 (6.7) 5.0-5.0 5.0 (-) - - - -*
Sanguineous 2 (13.3) 1.1-4.6 2.7 (2.3) 3 (20.0) 0.7-4.0 1.3 (1.7) 0.180u
Serosanguineous 5 (33.3) 1.1-5.0 3.0 (1.7) 11 (73.3) 0.8-4.5 1.1 (0.3) 0.043u
Wound odor
Present 1 (6.7) 4.3-4.3 4.3 (-) - - - -*
Absent 14 (93.3) 1.1-5.5 2.7 (1.6) 15 (100) 0.7-4.5 1.1 (0.6) 0.001u
Change frequency
Once a day 11 (73.3) 1.1-5.5 2.7 (1.7) 12 (80.0) 0.7-4.5 1.1 (0.3) 0.004u
Twice a day 4 (26.7) 1.4-4.4 3.2 (1.4) 3 (20.0) 0.7-4.0 0.8 (1.9) 0.140u
Total 15 (100) 1.1-5.5 2.8 (1.6) 15 (100) 0.7-4.5 1.1 (0.5) 0.002t
Legend: M (±SD): mean and standard deviation; Min-Max: minimum and maximum costs; t: significance of Student’s t-test; u: significance of the Wilcoxon Signed-Rank 
test; *Insufficient number of valid decimal places to conduct test. Note: (n=15).
Regarding wound surface area, between initial and final 
assessment, there were statistically significant differences 
in total costs (p=0.002). Furthermore, throughout the same 
interval, PUSH scores decreased USD 1.2 (p=0.001). In 
PUs with serosanguineous exudate, the difference was USD 
1.9 (p=0.043).
Significant differences were also found in wounds with 
no odor, in which dressing-related costs decreased USD 1.6 
(p=0.001), and in the frequency of one dressing change per 
day, with a USD 1.6 difference (p=0.004) between the first 
and last assessment. For dressings changed every two days, 
the initial mean cost with materials was four times greater 
than the last assessment, however, the difference was not 
statistically significant. The mean total cost between assess-
ments presented a statistically significant reduction of USD 
1.7 between assessments (p=0.002), corresponding to 60.7% 
of the initial value (Table 3).
DISCUSSION
Cost assessment of dressing materials was associated 
with PU characteristics. The indicators measured through 
the PUSH scale demonstrated an overall improvement in 
wound healing. The positive evolution of the wounds in this 
study was associated with significant cost reduction.
High incidence and prevalence rates of PU in critical 
care patients significantly impact health service costs. A 
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prospective cohort study identified that the amount of PUs 
was positively correlated with wound care costs in intensive 
care units(11).
The study sample (15 patients) was composed mainly by 
women, with incomplete elementary education. However, 
studies conducted in intensive care units with samples of 
40 to 563 patients, reported a higher incidence among male 
patients(11-12), even though there was no statistically significant 
difference between treatment costs and gender. It is worth 
mentioning that lower education levels may compromise 
patient understanding of the orientations provided by the mul-
tiprofessional health team during hospital stay or at discharge.
Among the comorbidities presented, the most predomi-
nant were systemic arterial hypertension and diabetes mel-
litus. The most significant risk factors for developing PU are 
immobility, skin aspect (dryness, erythema, and pre-existing 
injuries), and blood perfusion. A vital sign that is compro-
mised in patients with diabetes and vascular, circulatory and 
pressure disorders, as altered blood flow can lead to ischemia 
and the development of ulcers, in addition to delaying the 
healing process(13-14).
Another risk factor to consider is the participants’ nutri-
tional condition, as 26.6% were at nutritional risk. Good 
nutrition is essential to PU prevention. There is evidence 
suggesting improvement of wound healing in patients 
in good nutritional conditions, and positive effects are 
observed when nutritional interventions are conducted 
during PU treatment(15-16).
The fact that all patients were bedridden may have con-
tributed to the emergence of PUs, all located in the sacral 
region. Being bedridden reduces the ability to relieve pressure 
on bony prominences, maintaining pressure intensity and 
duration(13), even with the use of pneumatic mattresses with 
pressure redistribution surfaces that reduce the probability 
of ulcer formation(17). It is worth mentioning the importance 
of position changes according to patients’ clinical conditions, 
30º backrest elevation, daily skin assessment and the use of 
dietary supplements in PU prevention and treatment(10,18).
There was a considerable reduction in PUSH scores and 
mean wound surface area between the first and last assessments. 
Assessment of the PUSH scores demonstrated that although 
most of the PUs maintained the same healing level, some 
improved in the assessment interval. This finding shows that, 
in general, the wounds presented positive healing processes.
However, wound healing cannot be attributed solely 
to wound care dressing. The process of PU development is 
multifactorial, including environmental and patient-specific 
variables. The influence of environmental variables can be 
intensified by the nursing team care management and the 
institution’s structural characteristics(19).
Pressure ulcer treatment includes the use of dressings, 
and among the materials seen in this study, some were ele-
mentary and present in all the observations, such as proce-
dure gloves, sterile gloves, sterile gauze, 0.9% saline solution 
and micropore tape. Procedure gloves are personal protection 
equipment and were used in this study to remove previous 
dressings; the sterile gloves were used to reduce the probabil-
ity of wound contamination by exogenous infectious agents.
Saline solutions were used to clean wounds either by 
moistening dressings or direct applying the solution in 
spurts. Gauze was used as primary and secondary dress-
ings, protecting the wound against the action of exogenous 
agents, which justifies its intense use. In general, PUs are 
open wounds that require occlusive dressings, hence the 
importance of treatment materials(12).
Sterile compresses were used less frequently on wounds; 
however, when used, they implied significantly increased 
costs, contributing to higher mean total costs. The compresses 
used in the facility, acquired through procurement, came in 
packs of five. Every time a compress was necessary, a new 
pack was opened and unused compresses had to be discarded.
Industrialized wound dressings were not used in the 
observed procedures, only topical treatments, such as the 
use of essential fatty acids (EFA), papain, and silver sulfa-
diazine. Linoleic and linolenic acids are the most impor-
tant fatty acids for wound treatment and, in general, they 
are applied on wounds with granulation tissue. There is no 
strong scientific evidence establishing the effectiveness of 
EFA in wound healing among humans(20). However, it is 
widely used in Brazil in wound prevention and treatment, 
possibly for cultural and economic reasons.
In this study, only two papain concentrations were avail-
able, 8% and 10%, which made it difficult to choose the best 
option. Papain can be applied in wound debridement and 
presents anti-inflammatory action, helping wound edges 
contract and pull together through healing by second inten-
tion. It is available in different concentrations according to 
wound tissue type(21). Nurses are responsible for constantly 
assessing wounds and selecting suitable dressings for treat-
ment, which promote healing and cure.
Silver sulfadiazine is an antibacterial and antifungal drug 
based on the activity of Ag+ ions. It can be applied in a wide 
range of conditions, and is effective against Pseudomonas 
aeruginosa. This topical treatment is usually used in burn 
patients to help prevent and treat wound infections(22).
The mean total cost of dressing materials was consider-
able, even without the use of industrialized dressings, which 
vary in cost and depend on the size and severity of PU(23). 
Pressure ulcers take a long time to heal, so despite the appar-
ent low unit cost of the materials used, when multiplied by 
the number of times used, PU generate high costs for hos-
pitals. Furthermore, inadequate use of the materials leads to 
waste, which is not necessarily related to using more than is 
needed, as low expenditure coupled with poor use can also 
lead to waste(24).
Regarding cost assessment, lower values were observed 
among stage 4, stage 3, nonstageable and stage 2 ulcers, in 
this order. Classification of PU by stages represents one of 
the reference characteristics when assessing dressing costs. In 
general, costs are directly proportional to stage of PU, being 
that the greater the severity of wounds, the higher the costs. 
This is due to the association between stage 4 ulcers and 
higher costs of materials, longer treatment, greater amount 
needed, and higher incidence of complications(25).
The total mean cost of unstageable PUs was between the 
average cost found in stage 2 and 3. This finding corroborates 
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a study developed in Canada in 1,000 hospitals with a sam-
ple of 3,874 PUs, in which the cost of hospital-acquired 
unstageable PUs also fell between these two PU categories, 
while the total average cost of PUs developed before admis-
sion was lower than that of stage 2(26). The data indicate lack 
of linearity in treatment costs associated with nonstageable 
ulcers. This absence of proportionality may be due to the 
variability of characteristics presented by these types of PU, 
in which there is no standardized procedure.
The comparison between the initial and final costs of 
wound dressing material revealed a statistically significant 
cost reduction between one assessment and the other. This 
finding may be attributed to the clinical improvement of 
PUs, which consequently led to fewer necessary materials 
and dressing changes. The costs of PU treatment were directly 
correlated with the healing stage and aspect of wound bed.
One of the main factors influencing costs was the fre-
quency of dressing changes. In this study, dressings were 
changed daily, primarily once a day. Dressing changes 
depend on the presence of infection, type of dressing, wound 
location, and exudate amount(27). Furthermore, traditional 
dressings require more frequent changes in comparison with 
industrial dressings, which present higher levels of evidence 
as to the effectiveness of wound healing over shorter periods 
of time and that contribute to cost reduction(28).
The average cost of the materials used presented a sig-
nificant difference between the first and last assessments, 
dropping 60.7% between one and the other. Quick PU 
healing may contribute to cost savings for health systems; 
however, there are few studies that expressively analyze the 
cost-benefit relationship of prophylactic and curative mea-
sures to reduce PU incidence or improve treatment outcomes 
and the quality of life of critical patients(26,28).
In addition to direct costs, which correspond to the 
material and human resources that are immediately required 
in interventions, there are also indirect costs. These are of a 
social nature, associated with loss of work productivity due to 
illness and the time required to heal chronic wounds, such as 
stage 3 and 4 PUs. Indirect costs also include working days 
lost, patient pain and suffering, and the consequential nega-
tive impact on the quality of life and expenses of patients 
and their family members(6).
Some PUs improved, as indicated by lower PUSH scores 
and reduced costs. However, in general, on considering the 
assessment interval (20 days), treatment may not have been 
significant if a broader verification interval had been used. 
Both conditions can determine the relationship between 
treatment and costs with dressing materials.
Limitations of this study include its sample size, which 
does not allow for the generalization of results, and the num-
ber of observations, which did not include all the dress-
ings performed throughout the entire PU treatment span. 
Additionally, the institution did not work with industrialized 
dressings, an organizational factor that limited the compari-
son of different treatment techniques and options. The data 
were explored especially within a technical context, consider-
ing the scarce production of articles with clear stratified cal-
culations to determine the cost of wound-dressing materials.
CONCLUSION
The present study showed a proportional relationship 
between cost and PU stage, in that the more severe the injury, 
the higher the cost of treatment. Furthermore, a statistically 
significant cost reduction was observed between the initial 
and final observation. Most of the wounds remained stable 
in terms of PUSH scores, however, when considering wound 
characteristics, a positive healing process was observed.
This improvement cannot be attributed solely to wound 
care dressing, but also to a set of factors that involve patient-
specific and environmental characteristics. Nurses have an 
important role in creating plans and developing protocols to 
guide and systematize evidence-based care to improve PU 
care management in hospitals.
RESUMO
Objetivo: Avaliar o custo direto com curativos no tratamento de lesões por pressão. Método: Estudo observacional descritivo, realizado 
em Unidade de Terapia Intensiva do nordeste do Brasil, de novembro a dezembro de 2015. Foi aplicada a Pressure Ulcer Scale for 
Healing e formulário para caracterização e avaliação de custos. Os valores da moeda brasileira (R$) foram convertidos para a moeda 
norte-americana (US$) à taxa de US$0,26/R$. Foram realizadas análises univariadas e bivariadas. Resultados: Compuseram a amostra 
15 pacientes com lesões, no mínimo, estágio 2. Houve redução significativa dos custos com materiais de curativos entre as avaliações 
inicial e final (p=0,002), com média de US$11,9 (±7,4). As terapias tópicas mais frequentes foram ácidos graxos essenciais e papaína. 
Conclusão: Verificou-se redução de custos proporcional aos estágios das lesões. Enfatiza-se o papel do enfermeiro na elaboração de 
planos de cuidados baseados em evidências para melhor gerenciamento do cuidado.
DESCRITORES
Úlcera por Pressão; Custos e Análise de Custo; Bandagens; Cuidados de Enfermagem.
RESUMEn
Objetivo: Evaluar el costo directo de curativos para el tratamiento de lesiones por presión. Método: Estudio observacional descriptivo 
en la Unidad de Cuidados Intensivos del noreste de Brasil, de noviembre a diciembre del año 2015. Se aplicó la Pressure Ulcer Scale for 
Healing y formulario para la caracterización y evaluación de los costos. Los valores de la moneda brasileña (Reales- R$) se convirtieron 
al dólar estadounidense (US$) a razón de $0.26/R$. Se realizaron análisis univariados y bivariados. Resultados: La muestra consistió 
en 15 pacientes con lesiones al menos en Etapa 2. Hubo una reducción significativa en el costo de los materiales de curación entre las 
evaluaciones inicial y final (p=0,002), con un promedio de US$11.9 (±7.4). Los tratamientos tópicos más comunes son los ácidos grasos 
esenciales y papaína. Conclusión: Se verificó una reducción de los costos proporcional a las etapas de las lesiones. Se hace hincapié en el 
papel de los enfermeros en el desarrollo de planes de cuidados basados en la evidencia, para una mejor gestión de la atención.
DESCRIPTORES
Úlcera por Presión; Costos y Análisis de Costo; Vendajes; Atención de Enfermería.
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